Abstract
Purpose
The aim of this article is to conduct a comprehensive systematic review about the current understandings and differential diagnosis of myopic choroidal neovascularization (mCNV) and other several similar diseases, describing their multimodal imaging analysis, prognostic implications, and current types of management.
Methods
This systematic review was performed based on a search on the PubMed database of relevant papers regarding mCNV and other entities discussed in the paper, according to our current knowledge.
Results
Through the integration of a multimodal imaging approach, especially optical coherence tomography (OCT), along with accurate demographic and clinical assessment, it becomes possible to effectively differentiate mCNV from similar yet heterogeneous entities. These conditions include macular hemorrhage due to new lacquer crack (LC) formation, inflammatory diseases such as punctate inner choroidopathy (PIC)/multifocal choroidits (MFC) and epiphenomenon multiple evanescent white dot syndrome (Epi-MEWDS), neovascular age-related macular degeneration (nAMD), idiopathic CNV (ICNV), dome-shaped macula (DSM) with subretinal fluid, retinal pigment epithelium (RPE) humps, angioid streaks (AS), choroidal rupture (CR), and choroidal osteoma (CO). Each one of these entities will be described and discussed in this article.
Conclusion
Myopic choroidal neovascularization is a common retinal condition, especially among young individuals. Accurate diagnosis and differentiation from similar conditions are crucial for effective treatment. Multimodal imaging, particularly OCT, plays a crucial role in precise assessment. Future research should focus on defining biomarkers and distinguishing features to facilitate prompt treatment.
Similar content being viewed by others
Abbreviations
- AMD:
-
Age-related macular degeneration
- AS:
-
Angioid streaks
- BM:
-
Bruch’s membrane
- CC:
-
Choriocapillaris
- CNV:
-
Choroidal neovascularization
- CO:
-
Choroidal osteoma
- CR:
-
Choroidal rupture
- DSM:
-
Dome-shaped macula
- EDI:
-
Enhanced-depth imaging
- ELM:
-
External limiting membrane
- EZ:
-
Ellipsoid zone
- FA:
-
Fluorescein angiography
- FAF:
-
Fundus autofluorescence
- HM:
-
High myopia
- iCNV:
-
Inflammatory CNV
- ICNV:
-
Idiopathic CNV
- ICGA:
-
Indocyanine green angiography
- IMH:
-
Idiopathic macular hemorrhage
- IRC:
-
Intraretinal cyst
- LC:
-
Lacquer crack
- MEWDS:
-
Multiple evanescent white dot syndrome
- MFC:
-
Multifocal choroiditis
- MNV:
-
Macular neovascularization
- mCNV:
-
Myopic choroidal neovascularization
- nAMD:
-
Neovascular AMD
- NIR:
-
Near-infrared reflectance
- OCT:
-
Optical coherence tomography
- OCTA:
-
Optical coherence tomography angiography
- PDT:
-
Photodynamic therapy
- PIC:
-
Punctate inner choroidopathy
- PM:
-
Pathologic myopia
- PRN:
-
Pro re nata
- PXE:
-
Pseudoxantoma elasticum
- RD:
-
Retinal detachment
- RPE:
-
Retinal pigment epithelium
- SHRM:
-
Subretinal hyperreflective material
- SD-OCT:
-
Spectral domain OCT
- SRF:
-
Subretinal fluid
- TTT:
-
Transpupillary thermotherapy
- VA:
-
Visual acuity
- VEGF:
-
Vascular endothelial growth factor
- WSS:
-
White spot syndrome
References
Saw SM, Katz J, Schein OD et al (1996) Epidemiology of myopia. Epidemiol Rev 18:175–187. https://doi.org/10.1093/oxfordjournals.epirev.a017924
Wong TY, Ferreira A, Hughes R, et al (2014) Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 157. https://doi.org/10.1016/j.ajo.2013.08.010
Ng DSC, Lai TYY (2022) Insights into the global epidemic of high myopia and its implications. JAMA Ophthalmol 140:123–124. https://doi.org/10.1001/jamaophthalmol.2021.5347
Holden BA, Fricke TR, Wilson DA et al (2016) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123:1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006
Ng DSC, Chan LKY, Lai TYY (2023) Myopic macular diseases: a review. Clin Exp Ophthalmol 51:229–242. https://doi.org/10.1111/ceo.14200
Grossniklaus HE, Green WR (1992) Pathologic findings in pathologic myopia. Retina 12:127–133. https://doi.org/10.1097/00006982-199212020-00009
Ohno-Matsui K, Kawasaki R, Jonas JB et al (2015) International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 159:877–83.e7. https://doi.org/10.1016/j.ajo.2015.01.022
Ruiz-Medrano J, Montero JA, Flores-Moreno I et al (2019) Myopic maculopathy: current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res 69:80–115. https://doi.org/10.1016/j.preteyeres.2018.10.005
Avila MP, Weiter JJ, Jalkh AE et al (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581. https://doi.org/10.1016/s0161-6420(84)34116-1
Cohen SY, Laroche A, Leguen Y et al (1996) Etiology of choroidal neovascularization in young patients. Ophthalmology 103:1241–1244. https://doi.org/10.1016/s0161-6420(96)30515-0
Kobayashi K, Mandai M, Suzuma I et al (2002) Expression of estrogen receptor in the choroidal neovascular membranes in highly myopic eyes. Retina 22:418–422. https://doi.org/10.1097/00006982-200208000-00004
Yokoi T, Ohno-Matsui K (2018) Diagnosis and treatment of myopic maculopathy. Asia-Pacific J Ophthalmol 7:415–421. https://doi.org/10.22608/APO.2018290
Ho S, Ly A, Ohno-Matsui K et al (2023) Diagnostic accuracy of OCTA and OCT for myopic choroidal neovascularisation: a systematic review and meta-analysis. Eye (Lond) 37:21–29. https://doi.org/10.1038/s41433-022-02227-8
Ang M, Wong CW, Hoang QV et al (2019) Imaging in myopia: potential biomarkers, current challenges and future developments. Br J Ophthalmol 103:855–862. https://doi.org/10.1136/bjophthalmol-2018-312866
Feo A, Stradiotto E, Sacconi R, et al (2023) Subretinal hyperreflective material (SHRM) in retinal and chorioretinal disorders: a comprehensive review. Surv Ophthalmol
Parodi MB, Iacono P, Sacconi R et al (2015) Fundus autofluorescence changes after ranibizumab treatment for subfoveal choroidal neovascularization secondary to pathologic myopia. Am J Ophthalmol 160:322-327.e2. https://doi.org/10.1016/j.ajo.2015.04.030
Iacono P, Battaglia Parodi M, Selvi F et al (2017) Factors influencing visual acuity in patients receiving anti-vascular endothelial growth factor for myopic choroidal neovascularization. Retina 37:1931–191. https://doi.org/10.1097/IAE.0000000000001436
Li M, Zhang X, Wen F (2015) The fundus autofluorescence spectrum of punctate inner choroidopathy. J Ophthalmol 2015:202097. https://doi.org/10.1155/2015/202097
Ma F, Yuan M, Kozak I (2023) Multispectral imaging: review of current applications. Surv Ophthalmol 68:889–904. https://doi.org/10.1016/j.survophthal.2023.06.004
Klein RM, Green S (1988) The development of lacquer cracks in pathologic myopia. Am J Ophthalmol 106:282–285. https://doi.org/10.1016/0002-9394(88)90362-5
Choudhury F, Meuer SM, Klein R et al (2018) Prevalence and characteristics of myopic degeneration in an adult Chinese American population: the Chinese American Eye Study. Am J Ophthalmol 187:34–42. https://doi.org/10.1016/j.ajo.2017.12.010
Haarman AEG, Tedja MS, Brussee C et al (2022) Prevalence of myopic macular features in Dutch individuals of European ancestry with high myopia. JAMA Ophthalmol 140:115–123. https://doi.org/10.1001/jamaophthalmol.2021.5346
Klein RM, Curtin BJ (1975) Lacquer crack lesions in pathologic myopia. Am J Ophthalmol 79:386–392. https://doi.org/10.1016/0002-9394(75)90611-x
Ohno-Matsui K, Tokoro T (1996) The progression of lacquer cracks in pathologic myopia. Retina 16:29–37. https://doi.org/10.1097/00006982-199616010-00006
Ohno-Matsui K, Yoshida T, Futagami S et al (2003) Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 87:570–3. https://doi.org/10.1136/bjo.87.5.570
Crincoli E, Ferrara S, Miere A et al (2023) Correlation between AI-measured lacquer cracks extension and development of myopic choroidal neovascularization. Eye (Basingstoke). https://doi.org/10.1038/s41433-023-02451-w
Xu X, Fang Y, Uramoto K et al (2019) Clinical features of lacquer cracks in eyes with pathologic myopia. Retina 39:1265–1277. https://doi.org/10.1097/IAE.0000000000002168
Liu C-F, Liu L, Lai C-C et al (2014) Multimodal imaging including spectral-domain optical coherence tomography and confocal near-infrared reflectance for characterization of lacquer cracks in highly myopic eyes. Eye (Lond) 28:1437–1445. https://doi.org/10.1038/eye.2014.221
Ren P, Lu L, Tang X et al (2020) Clinical features of simple hemorrhage and myopic choroidal neovascularization associated with lacquer cracks in pathologic myopia. Graefes Arch Clin Exp Ophthalmol 258:2661–2669. https://doi.org/10.1007/s00417-020-04778-6
Battista M, Sacconi R, Borrelli E et al (2022) Discerning between macular hemorrhages due to macular neovascularization or due to spontaneous Bruch’s membrane rupture in high myopia: a comparative analysis between OCTA and fluorescein angiography. Ophthalmol Ther 11:821–831. https://doi.org/10.1007/s40123-022-00484-0
Mularoni C, Servillo A, Sacconi R et al (2023) ’Structural OCT changes distinguishing between myopic macular haemorrhages due to choroidal neovascularization and spontaneous Bruch’s membrane rupture: the “myopic 2 binary reflective sign.” Eye (Lond). https://doi.org/10.1038/s41433-023-02780-w
Essex RW, Wong J, Jampol LM et al (2013) Idiopathic multifocal choroiditis: a comment on present and past nomenclature. Retina 33:1–4. https://doi.org/10.1097/IAE.0b013e3182641860
Cicinelli MV, Ramtohul P, Marchese A et al (2023) Latest advances in white spot syndromes: new findings and interpretations. Prog Retin Eye Res 97:101207. https://doi.org/10.1016/j.preteyeres.2023.101207
Kedhar SR, Thorne JE, Wittenberg S et al (2007) Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina 27:1174–1179. https://doi.org/10.1097/IAE.0b013e318068de72
Standardization of Uveitis Nomenclature (SUN) Working Group (2021) Classification criteria for multiple evanescent white dot syndrome. Am J Ophthalmol 228:198–204. https://doi.org/10.1016/j.ajo.2021.03.050
Levison AL, Baynes KM, Lowder CY et al (2017) Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis. Br J Ophthalmol 101:616–622. https://doi.org/10.1136/bjophthalmol-2016-308806
Zahid S, Chen KC, Jung JJ et al (2017) Optical coherence tomography angiography of chorioretinal lesions due to idiopathic multifocal choroiditis. Retina 37:1451–1463. https://doi.org/10.1097/IAE.0000000000001381
Hoang QV, Cunningham ET, Sorenson JA, Freund KB (2013) The “pitchfork sign” a distinctive optical coherence tomography finding in inflammatory choroidal neovascularization. Retina 33:1049–1055. https://doi.org/10.1097/IAE.0b013e31827e25b8
Gallego-Pinazo R, Hernández S, Dolz-Marco R (2021) Key multimodal fundus imaging findings to recognize multifocal choroiditis in patients with pathological myopia. Front Med (Lausanne) 8:831764. https://doi.org/10.3389/fmed.2021.831764
Zicarelli F, Azzolini C, Cornish E et al (2021) Optical coherence tomography features of choroidal neovascularization and their correlation with age, gender, and underlying disease. Retina 41:1076–1083. https://doi.org/10.1097/IAE.0000000000002984
Falavarjani KG, Au A, Anvari P et al (2019) En face OCT of type 2 neovascularization:a reappraisal of the pitchfork sign. Ophthalmic Surg Lasers Imaging Retina 50:719–725. https://doi.org/10.3928/23258160-20191031-07
Shi X, Cai Y, Luo X et al (2020) Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes. Graefes Arch Clin Exp Ophthalmol 258:751–758. https://doi.org/10.1007/s00417-019-04571-0
Giuffrè C, Marchese A, Fogliato G et al (2021) The “Sponge sign”: a novel feature of inflammatory choroidal neovascularization. Eur J Ophthalmol 31:1240–1247. https://doi.org/10.1177/1120672120917621
Gao R, Ma J, Zhang Z et al (2021) Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization. Ann Med 53:1270–1278. https://doi.org/10.1080/07853890.2021.1961015
Hady SK, Xie S, Freund KB et al (2022) Prevalence and characteristics of multifocal choroiditis/ punctate inner choroidopathy in pathologic myopia eyes with patchy atrophy. Retina 42:669–678. https://doi.org/10.1097/IAE.0000000000003383
de Groot EL, de Boer JH, Ossewaarde-van Norel J (2022) Idiopathic multifocal choroiditis and punctate inner choroidopathy - evaluation of risk factors for increased relapse rate: a 2-year prospective observational cohort study. Ophthalmologica 245:476–486. https://doi.org/10.1159/000526663
Cicinelli MV, Marchese A, Ramtohul P et al (2022) Punctate inner choroidopathy-like reactions in unrelated retinal diseases. Retina 42:2099–2109. https://doi.org/10.1097/IAE.0000000000003602
Invernizzi A, Pichi F, Symes R et al (2020) Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens. Br J Ophthalmol 104:1052–1056. https://doi.org/10.1136/bjophthalmol-2019-315257
Kim M, Lee J, Park Y-G, Park Y-H (2022) Long-term analysis of clinical features and treatment outcomes of inflammatory choroidal neovascularization. Am J Ophthalmol 233:18–29. https://doi.org/10.1016/j.ajo.2021.07.014
Ramtohul P, Cicinelli MV, Dolz-Marco R et al (2023) The chrysanthemum phenotype of idiopathic multifocal choroiditis. Retina 43:1377–1385. https://doi.org/10.1097/IAE.0000000000003815
de Groot EL, Ten Dam-van Loon NH, Kouwenberg CV et al (2023) Exploring imaging characteristics associated with disease activity in idiopathic multifocal choroiditis: a multimodal imaging approach. Am J Ophthalmol 252:45–58. https://doi.org/10.1016/j.ajo.2023.03.022
Kongwattananon W, Grasic D, Lin H et al (2022) Role of optical coherence tomography angiography in detecting and monitoring inflammatory choroidal neovascularization. Retina 42:1047–1056. https://doi.org/10.1097/IAE.0000000000003420
D’Ambrosio E, Tortorella P, Iannetti L (2014) Management of uveitis-related choroidal neovascularization: from the pathogenesis to the therapy. J Ophthalmol 2014:450428. https://doi.org/10.1155/2014/450428
Ramakrishnan MS, Patel AP, Melles R, Vora RA (2021) Multiple evanescent white dot syndrome: findings from a large Northern California cohort. Ophthalmol Retina 5:850–854. https://doi.org/10.1016/j.oret.2020.11.016
Testi I, Modugno RL, Pavesio C (2021) Multimodal imaging supporting the pathophysiology of white dot syndromes. J Ophthalmic Inflamm Infect 11:32. https://doi.org/10.1186/s12348-021-00261-3
Papasavvas I, Mantovani A, Tugal-Tutkun I, Herbort CP (2021) Multiple evanescent white dot syndrome (MEWDS): update on practical appraisal, diagnosis and clinicopathology; a review and an alternative comprehensive perspective. J Ophthalmic Inflamm Infect 11:45. https://doi.org/10.1186/s12348-021-00279-7
Essilfie J, Bacci T, Abdelhakim AH et al (2022) Are there two forms of multiple evanescent white dot syndrome? Retina 42:227–235. https://doi.org/10.1097/IAE.0000000000003288
Ho AC, Yannuzzi LA, Pisicano K, DeRosa J (1995) The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 102:782–789. https://doi.org/10.1016/s0161-6420(95)30968-2
Machida S, Fujiwara T, Murai K-I et al (2008) Idiopathic choroidal neovascularization as an early manifestation of inflammatory chorioretinal diseases. Retina 28:703–710. https://doi.org/10.1097/IAE.0b013e318160798f
Yin H, Fang X, Ma J et al (2016) Idiopathic choroidal neovascularization: intraocular inflammatory cytokines and the effect of intravitreal ranibizumab treatment. Sci Rep 6:31880. https://doi.org/10.1038/srep31880
Fine SL, Berger JW, Maguire MG, Ho AC (2000) Age-related macular degeneration. N Engl J Med 342:483–492. https://doi.org/10.1056/NEJM200002173420707
Spaide RF, Jaffe GJ, Sarraf D et al (2020) Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology 127:616–636. https://doi.org/10.1016/j.ophtha.2019.11.004
Keane PA, Liakopoulos S, Chang KT et al (2008) Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis. Br J Ophthalmol 92:1081–1085. https://doi.org/10.1136/bjo.2008.138891
Wilkerson JL, Stiles MA, Gurley JM et al (2019) Sphingosine kinase-1 is essential for maintaining external/outer limiting membrane and associated adherens junctions in the aging retina. Mol Neurobiol 56:7188–7207. https://doi.org/10.1007/s12035-019-1599-x
Sayanagi K, Fujimoto S, Hara C et al (2022) Characteristics of choroidal neovascularization in elderly eyes with high myopia not meeting the pathologic myopia definition. Sci Rep 12:13795. https://doi.org/10.1038/s41598-022-18074-2
Ohno-Matsui K, Wu P-C, Yamashiro K et al (2021) IMI pathologic myopia. Invest Ophthalmol Vis Sci 62:5. https://doi.org/10.1167/iovs.62.5.5
Ricci F, Bandello F, Navarra P, et al (2020) Neovascular age-related macular degeneration: therapeutic management and new-upcoming approaches. Int J Mol Sci 21. https://doi.org/10.3390/ijms21218242
Wolf S, Balciuniene VJ, Laganovska G et al (2014) RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 121:682–92.e2. https://doi.org/10.1016/j.ophtha.2013.10.023
Chen Y, Sharma T, Li X et al (2019) Ranibizumab versus verteporfin photodynamic therapy in asian patients with myopic choroidal neovascularization: brilliance, a 12-month, randomized, double-masked study. Retina 39:1985–1994. https://doi.org/10.1097/IAE.0000000000002292
Hamilton RD, Clemens A, Minnella AM et al (2020) Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study. PLoS ONE 15:e0227557. https://doi.org/10.1371/journal.pone.0227557
Ikuno Y, Ohno-Matsui K, Wong TY et al (2015) Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology 122:1220–1227. https://doi.org/10.1016/j.ophtha.2015.01.025
Zhou Y, Yang S, Yuan Y et al (2020) Progression and new onset of macular retinoschisis in myopic choroidal neovascularization eyes after Conbercept therapy: a post-hoc analysis. Eye (Lond) 34:523–529. https://doi.org/10.1038/s41433-019-0516-x
Cui Z, Zhou W, Chang Q, et al (2021) Cost-effectiveness of conbercept vs. ranibizumab for age-related macular degeneration, diabetic macular edema, and pathological myopia: population-based cohort study and Markov model. Front Med (Lausanne) 8:750132. https://doi.org/10.3389/fmed.2021.750132
Jain M, Gopal L, Padhi TR (2021) Dome-shaped maculopathy: a review. Eye (Lond) 35:2458–2467. https://doi.org/10.1038/s41433-021-01518-w
Liang I-C, Shimada N, Tanaka Y et al (2015) Comparison of clinical features in highly myopic eyes with and without a dome-shaped macula. Ophthalmology 122:1591–1600. https://doi.org/10.1016/j.ophtha.2015.04.012
Pozzo Giuffrida F, Leone G, Mainetti C et al (2022) Response to treatment of choroidal neovascularization in highly myopic eyes with dome-shaped macula: two years of follow-up. Retina 42:1057–1064. https://doi.org/10.1097/IAE.0000000000003431
Viola F, Dell’Arti L, Benatti E et al (2015) Choroidal findings in dome-shaped macula in highly myopic eyes: a longitudinal study. Am J Ophthalmol 159:44–52. https://doi.org/10.1016/j.ajo.2014.09.026
Arapi I, Neri P, Mariotti C et al (2015) Considering photodynamic therapy as a therapeutic modality in selected cases of dome-shaped macula complicated by foveal serous retinal detachment. Ophthalmic Surg Lasers Imaging Retina 46:217–223. https://doi.org/10.3928/23258160-20150213-15
Chinskey ND, Johnson MW (2013) Treatment of subretinal fluid associated with dome-shaped macula. Ophthalmic Surg Lasers Imaging Retina 44:593–595. https://doi.org/10.3928/23258160-20131010-01
Battaglia Parodi M, Iacono P, Bandello F (2018) Subthreshold laser treatment for serous retinal detachment in dome-shaped macula associated with pathologic myopia. Retina 38:359–363. https://doi.org/10.1097/IAE.0000000000001524
Dirani A, Matet A, Beydoun T et al (2014) Resolution of foveal detachment in dome-shaped macula after treatment by spironolactone: report of two cases and mini-review of the literature. Clin Ophthalmol 8:999–1002. https://doi.org/10.2147/OPTH.S62267
Marchese A, Arrigo A, Sacconi R et al (2019) Spectrum of choroidal neovascularisation associated with dome-shaped macula. Br J Ophthalmol 103:1146–1151. https://doi.org/10.1136/bjophthalmol-2018-312780
Shin YK, Han SH, Kang SW et al (2021) Myopic foveal detachment associated with pachychoroid characteristics. BMC Ophthalmol 21:288. https://doi.org/10.1186/s12886-021-02040-z
Marchese A, Carnevali A, Sacconi R et al (2017) Retinal pigment epithelium humps in high myopia. Am J Ophthalmol 182:56–61. https://doi.org/10.1016/j.ajo.2017.07.013
Marchese A, Cicinelli MV, Carnevali A et al (2020) Complicated retinal pigment epithelium humps in high myopia. Ophthalmic Surg Lasers Imaging Retina 51:119–123. https://doi.org/10.3928/23258160-20200129-09
Chatziralli I, Saitakis G, Dimitriou E et al (2019) Angioid streaks: a comprehensive review from pathophysiology to treatment. Retina 39:1–11. https://doi.org/10.1097/IAE.0000000000002327
Rohart C, Le H-M, Estrada-Walker J et al (2023) Long-term prognosis of choroidal neovascularization complicating angioid streaks. Retina. https://doi.org/10.1097/IAE.0000000000003746
Cicinelli MV, Torrioli E, La Franca L et al (2023) Incidence and risk factors of visual impairment in patients with angioid streaks and macular neovascularization. Ophthalmol Retina 7:431–440. https://doi.org/10.1016/j.oret.2022.12.002
Lupidi M, Muzi A, Castellucci G et al (2021) The choroidal rupture: current concepts and insights. Surv Ophthalmol 66:761–770. https://doi.org/10.1016/j.survophthal.2021.01.014
Wood CM, Richardson J (1990) Chorioretinal neovascular membranes complicating contusional eye injuries with indirect choroidal ruptures. Br J Ophthalmol 74:93–96. https://doi.org/10.1136/bjo.74.2.93
Lorusso M, Micelli Ferrari L, Nikolopoulou E et al (2019) Optical coherence tomography angiography evolution of choroidal neovascular membrane in choroidal rupture managed by intravitreal bevacizumab. Case Rep Ophthalmol Med 2019:5241573. https://doi.org/10.1155/2019/5241573
Singh S, Saxena S (2023) Unraveling the perplexities of choroidal rupture. Indian J Ophthalmol 71:2602–2603. https://doi.org/10.4103/IJO.IJO_326_23
Shields CL, Shields JA, Augsburger JJ (1988) Choroidal osteoma. Surv Ophthalmol 33:17–27. https://doi.org/10.1016/0039-6257(88)90069-0
Zhang L, Ran Q-B, Lei C-Y, Zhang M-X (2023) Clinical features and therapeutic management of choroidal osteoma: a systematic review. Surv Ophthalmol. https://doi.org/10.1016/j.survophthal.2023.06.002
Cennamo G, Iacucci G, Breve MA et al (2023) The role of choriocapillaris vessel density in the pathogenesis of macular neovascularization associated with choroidal osteoma. Graefes Arch Clin Exp Ophthalmol 261:1283–1287. https://doi.org/10.1007/s00417-022-05921-1
Bolletta E, De Simone L, Pellegrini M, et al (2023) Optical coherence tomography in inflammatory and neoplastic lesions deforming the choroidal profile. Diagnostics (Basel) 13s. https://doi.org/10.3390/diagnostics13121991
Cennamo G, Romano MR, Iovino C et al (2017) OCT angiography in choroidal neovascularization secondary to choroidal osteoma. Acta Ophthalmol 95:e152–e154. https://doi.org/10.1111/aos.13142
Furino C, Di Antonio L, Grassi MO et al (2019) Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: an optical coherence tomography angiography study. Eur J Ophthalmol 29:323–329. https://doi.org/10.1177/1120672118792187
Rajabian F, Arrigo A, Grazioli A, et al (2021) Focal choroidal excavation and pitchfork sign in choroidal neovascularisation associated with choroidal osteoma. Eur J Ophthalmol 31:NP67–NP70. https://doi.org/10.1177/1120672119892802
Seong HJ, Kim YJ, Choi EY et al (2022) Complications, treatments, and visual prognosis of choroidal osteomas. Graefes Arch Clin Exp Ophthalmol 260:1713–1721. https://doi.org/10.1007/s00417-021-05487-4
Kang HG, Kim TY, Lee J et al (2022) Predicting visual outcomes in choroidal osteoma treated with anti-vascular endothelial growth factor. Am J Ophthalmol 244:143–151. https://doi.org/10.1016/j.ajo.2022.08.007
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants of animals performed by any of the authors. This article is a review. Therefore, ethical approval by IRB was not required.
Informed consent
This article does not contain any studies with human participants.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Feo, A., De Simone, L., Cimino, L. et al. Differential diagnosis of myopic choroidal neovascularization (mCNV): insights from multimodal imaging and treatment implications. Graefes Arch Clin Exp Ophthalmol (2023). https://doi.org/10.1007/s00417-023-06320-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00417-023-06320-w